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Figure 1. Platelet rolling and attachment to VWF under flow. (a) Vena8 microchannels were coated with either full-
length VWF (FL-VWF; i-iii), VWF A1 (iv-vi) or A1* (vii-ix). Whole blood labeled with DiOC6 was perfused at 1000 s
 1.
Representative images (n = 3) of platelets (green) after 30, 90 and 180 s are shown. Scale; 50 mm (see also
Video 1). (b) Experiments performed as in a), bound platelets (blue) were tracked (depicted by multi-colored lines)
representing distance travelled in the first 30 s of flow. Scale bar; 50 mm. (c) Platelet rolling velocity on channels
coated with A1 and A1*. Data plotted are median ±95% CI. n = 3562 platelets from 3 different experiments (A1)
and n = 4047 platelets from 3 different experiments (A1*). Data were analyzed using the Mann-Whitney test.
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Figure 1—figure supplement 1. Analysis of purified recombinant VWF A1 and VWF A1*. VWF A1 domain with a
C-terminal V5 and 6xHis tag was expressed in S2 insect cells and purified to homogeneity. Purified A1 was
analyzed by SDS-PAGE and Coomassie staining under reducing and non-reducing conditions, and also by
Western blotting of VWF A1 using anti-6xHis and anti-VWF antibodies. A Coomassie stain of purified VWF A1* is
also shown.
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Figure 1—figure supplement 2. Platelet coverage on VWF A1, A1* and VWF surfaces. (a) Graph showing the
surface coverage over time of microchannels coated with FL-VWF, VWF A1 or VWF A1* by platelets in either
whole blood (WB) or plasma-free blood (PFB) at a shear rate of 1000 s 1 (b) Graph of the area under the curve
(AUC) ± SD of conditions analyzed in A) Surface coverage rates were similar on all surfaces.
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Figure 2. Platelet binding to VWF under flow induces aIIbb3-dependent aggregation. (a) Vena8 microchannels were coated with A1* via its 6xHis tag. (i)
Whole blood (WB) or ii) plasma-free blood (PFB), iii) WB containing eptifibatide or iv) WB containing GR144053 were perfused through channels at 1000
s 1. Representative images acquired after 3 min. Scale bar; 50 mm. (b) Graph measuring platelet aggregation over time in WB perfused through
channels coated with A1 (red, n = 3), A1* (purple, n = 4) and FL-VWF (blue, n = 3), WB pre-incubated with eptifibatide (orange, n = 3) or GR144053
(green, n = 4) over channels coated with A1* and PFB over channels coated with A1* (magenta, n = 3) or FL-VWF (teal, n = 3). Data plotted are
mean ± SD. (c–e) Bar charts comparing area under the curve (AUC) of the data presented in b). (c) WB perfused over A1 or A1* with or without
eptifibatide or GR144053. (d) WB or PFB perfused over A1*. (e) WB or PFB perfused over FL VWF. Data presented are mean ± SD, n = 3 or 4 as
indicated in b). Data were analyzed using the Mann-Whitney test.
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Figure 2—figure supplement 1. Platelets binding to VWF under flow are ‘primed’ leading to activation of aIIbb3,
but minimal presentation of P-selectin. (a) Representative images (n = 3) depicting platelets (DiOC6, green)
captured from plasma-free blood at 1000 s 1 for 3.5 min onto microchannel surfaces coated with either FL-VWF (i-
iii), anti-PECAM (iv-vi) or collagen (vii-ix). Plasma-free blood was supplemented with fibrinogen-Alexa647 (red).
Merged images show fluorescent fibrinogen attached to the platelets captured by FL-VWF and collagen, but not
by platelets captured by anti-PECAM. (b) Representative images (n = 3) depicting platelets (DiOC6, green)
captured from whole blood at 1000 s 1 for 3.5 min onto microchannel surfaces coated with either FL-VWF (i-iii) or
collagen (iv-vi). Blood was supplemented with anti-P-selectin-APC (red). Merged images show the presence of P-
selectin on the surface of platelets captured by collagen, but very little/no P-selectin on platelets captured FL-
VWF. Scale bar = 20 mm.
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Figure 3. Leukocytes bind to VWF-bound platelets under flow (see also Video 3). (a) Graph of the number of
leukocytes/minute in WB interacting with platelets bound to FL-VWF in the absence (n = 12) or presence of
eptifibatide/GR144053 (n = 5) or binding to platelets bound to anti-PECAM-1 antibody (n = 3). (b) Graph of the
number of leukocytes/minute in WB or PFB interacting with platelets bound to FL-VWF in the absence (n = 12) or
presence of 1.3 mg/ml fibrinogen (n = 3) or eptifibatide/GR144053 (n = 4), or binding to platelets bound to anti-
PECAM-1 antibody (n = 3). (c) Graph of the number of leukocytes/minute in PFB interacting with platelets bound
to A1* in the absence (n = 11) or presence of fibrinogen (n = 3) or eptifibatide/GR144053 (n = 4). (d) Graph of the
number of leukocytes/minute in PFB interacting with platelets bound to anti-PECAM-1 antibody in the absence
(n = 5) or presence of LIBS/anti-b3 activating antibody (n = 5)±GR144053 (n = 5). (e) Graph of the number of
leukocytes/minute in WB or PFB, as shown, interacting with platelets bound to FL-VWF in the absence or presence
of a blocking anti-P-selectin antibody. (f) Graph of leukocyte rolling velocity on platelets bound to FL-VWF in PFB
in the absence or presence of a blocking anti-P-selectin antibody. Data shown are individual leukocyte rolling
velocities (n=121 and 178, respectively) for three separate experiments. In all graphs, data plotted are mean ± SD.
Data were analyzed using unpaired, two-tailed Student’s t test; ns not significant.
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Figure 3—figure supplement 1. Antibody-mediated blockade of P-selectin diminishes leukocyte binding to
collagen bound platelets. (a) Vena8 microchannels were coated with FL-VWF. (i) Whole blood (WB), ii) plasma-free
blood (PFB), iii) WB containing anti-P-selectin blocking antibody, or iv) WB containing eptifibatide were perfused
through channels at 1000 s 1 for 3.5 min. Thereafter, the shear rate was reduced to 50 s 1 for 5 min. Platelets and
leukocytes were labeled with DiOC6, platelets are shown in green, leukocytes have been pseudo-colored red to
aid visualization. Scale bar; 50 mm (see also Video 3). (b) Whole blood (WB), labeled with DiOC6 was perfused
over collagen microchannels at 1000 s 1 for 3.5 min. Thereafter, the shear rate was reduced to 50 s 1 to monitor
leukocyte interactions. (i) Representative image (n = 3) shown after 5 min platelets (green) and leukocytes (pseudo-
colored red). (ii) as in (i) except WB was supplemented with a blocking anti-P-selectin antibody (AK-4 clone. Scale
bar = 50 mm. (c) The mean number of leukocytes binding per minute ± SD was calculated for each channel. There
was a significant reduction in the number of leukocytes binding to collagen-bound platelets in the presence of P-
selectin blocker, although leukocyte binding was not completely inhibited, suggesting that not all binding to
collagen-activated platelets is P-selectin-dependent. (d) Graph of leukocyte rolling velocity on platelets bound to
FL-VWF in WB in the absence or presence of a blocking anti-P-selectin antibody. Data shown are the means of
individual leukocyte rolling velocities for three separate experiments. Unpaired, two-tailed Student’s t test.
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Figure 4. Leukocytes bind to activated aIIbb3 under flow. (a) Purified aIIbb3 or BSA, as noted, were covalently
coupled to microchannel surfaces by amine coupling. aIIbb3 was activated using Mn
2+ and Ca2+ in all buffers.
PBMCs (i) or PMNs (ii-v) labeled with DiOC6 were perfused through channels at 50 s
 1 in the presence and
Figure 4 continued on next page
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Figure 4 continued
absence of eptifibatide (iv) or 1.3 mg/ml purified fibrinogen (v). Bound leukocytes (as opposed to flowing) are
pseudo-colored red to aid visualization and to distinguish from leukocytes in transit. Scale bar; 50 mm. (b)
Graphical representation of relative leukocyte binding to activated aIIbb3 in the presence and absence of
eptifibatide or 1.3 mg/ml purified fibrinogen, or to BSA after 15 min of PMN perfusion (n = 3), or to aIIbb3
captured and activated by LIBS/anti-b3 activating antibody in the absence and presence of GR144053 (n = 3). Data
plotted are mean ± SD. Data were analyzed using unpaired, two-tailed Student’s t test. (c) Graph of the number of
leukocytes/minute in PFB interacting with platelets bound to FL-VWF in the absence (n = 12) or presence of a
blocking anti-b2 integrin polyclonal antibody (n = 5) capable of blocking both LFA-1 or Mac-1 on leukocytes. (d)
PBMCs stained with Hoechst dye (i - blue), anti-CD3 (ii - red) and merged (iii). Representative of n = 4. Scale bar;
20 mm. (e) PFB stained with DiOC6 was perfused over FL-VWF at 1000 s 1 followed by 50 s 1. T-cells labeled with
anti-CD3 (red - arrows) were seen to attach to ‘primed’ platelets f) PMNs stained with Hoechst dye (i - blue), anti-
CD16 (ii - red) and merged (iii). Representative of n = 4. Scale bar; 20 mm (see also Video 4). (g) Images depicting
a neutrophil stained with anti-CD16 (red) ‘scanning’ the ‘primed’ platelets stained with DiOC6 (green). Images
shown were taken 10, 40, 70 and 100 s after neutrophil attachment note the movement of the neutrophil shown -
see also Video 4.
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Figure 5. Binding to aIIbb3 induces intracellular Ca
2+ release in neutrophils. (a) Representative images of
neutrophils pre-loaded with Fluo-4 AM bound to VWF-‘primed’ platelets captured (Video 5). Neutrophils are
numbered #1-#4. The yellow arrow highlights a frame in which the fluorescence has increased in the attached
neutrophil. For each neutrophil shown, intracellular Ca2+ release is quantified by measurement of cellular mean
fluorescent intensity (MFI) over time. (b) As in A) except neutrophils were perfused over activated aIIbb3. MFI
increased for neutrophils #1 and #3, but not for neutrophil #2. (c) Graph depicting the change in MFI as a function
of time after neutrophil attachment to microchannels coated with activated aIIbb3 (n = 24 neutrophils from three
different experiments), VWF-‘primed’ platelets (n = 9 neutrophils from one experiment) or anti-CD16 (n = 13
neutrophils from two different experiments). Data plotted are mean ± SEM. (d) Dot plot presenting the time
between neutrophil attachment and maximum MFI of neutrophils binding to purified aIIbb3 (red), or VWF-‘primed’
platelets (blue). Data plotted are median ±95% confidence interval. Data were analyzed using the Mann-Whitney
test.
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Figure 6. Binding of neutrophils to aIIbb3 under flow induces NETosis. (a) Isolated PMNs labeled with Hoechst
(blue) and cell-impermeable Sytox Green were perfused over aIIbb3-coated microchannels, or anti-CD16, (-ve ctrl)
at 50 s 1 for 10 min and then monitored under static conditions. Representative composite images after 20, 30, 75,
80, 85, 87, 90, 91 and 95 min of attachment. Neutrophils bound to aIIbb3 exhibited nuclear decondensation and
increased cell permeability that precedes NETosis after about 85 min, Sytox Green staining appears, indicative of
DNA becoming extracellular (see Video 6). Neutrophils bound to surfaces using an anti-CD16 antibody did not
exhibit signs of NETosis or did so very rarely. (b) Immunostaining of neutrophils bound to aIIbb3 after 90 mins as in
a). Hoechst (blue), citrullinated H3 (red) and merged images are shown. (c) Graph showing the mean % of
neutrophils ± SD in the entire microchannel that formed NETs after 2 hr of attachment on aIIbb3 (n = 8) or anti-
CD16 (n = 5), captured in the presence of flow (50 s 1/10 min), or captured on aIIbb3 under static/no flow
conditions (n = 3). (d) Graph showing the mean % of neutrophils ± SD in the entire microchannel that formed NETs
after 2 hr of attachment on anti-CD16 antibody in the presence of flow (50 s 1/10 min) (n = 5) in the presence of
PMA (n = 3), PMA and TMB-8 (n = 3) or PMA and DPI (n = 3). (e) Graph showing the mean % of neutrophils ± SD
in the entire microchannel that formed NETs after 2 hr of attachment on aIIbb3 in the presence of flow (50 s
 1/10
min) (n = 8) and in the presence of TMB-8 (n = 3) or DPI (n = 3), as noted. Data were analyzed using unpaired, two-
tailed Student’s t test; ns not significant.
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Figure 7. Transcriptomic profiling of human leukocytes. RNA sequencing data from different leukocytes were
obtained from the BLUEPRINT consortium (Grassi et al., 2019). Differential gene expression analyses were
performed: mature neutrophils (n = 7) vs monocytes (n = 5) and CD4-positive/ab T cells (n = 8) vs monocytes
(n = 5). Regulatory T cells (Treg, n = 1) and native B cells (n = 1), are included in the heatmap, for comparison but
were not used in differential gene expression analysis due to the low number of biological replicates. We first
Figure 7 continued on next page
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Figure 7 continued
selected genes that were expressed significantly higher in neutrophils than in monocytes, and also those that were
significantly higher in CD4-positive/ab T cells than in monocytes. Their intersection identified 750 genes (598 of
which protein coding). From these 598 genes, we selected the 93 genes that contained the Uniprot annotation of
‘INTRAMEMBRANE DOMAIN’ or ‘TRANSMEM DOMAIN’. The effective log2(FPKM+1) data are presented in the
heatmap of the 93 genes, with the rows ordered according to the mean neutrophil expression levels. Next to the
heatmap is a table highlighting the subsequent selection criteria used to further narrow the search for candidate
receptors for aIIbb3. The first round of selection involved discarding those transmembrane proteins that are not
present on the extracellular membrane, or primarily associated with intracellular membranes. The second selection
criterion was to discard those proteins that had extracellular regions of <30 amino acids that might be less likely
capable of mediating specific ligand binding. Finally, analysis of proteomic data from the ImmProt (http://
immprot.org) resource was used to verify higher levels of protein of each selected gene in neutrophils than in
monocytes.
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Figure 7—figure supplement 1. SLC44A2 expression in neutrophils and SLC44A2 genotype analysis. (a)
Preferential expression of SLC44A2 in neutrophils over monocytes was ascertained through analysis of proteomic
data from ImmProt (http://immprot.org), which is based on high-resolution mass-spectrometry proteomics
performed on human hematopoietic cell populations in either steady or activated states. A pair-wise comparison
between neutrophils (steady-state) and classical monocytes (steady state) is displayed as a volcano plot. Protein
expression levels were compared using two-tailed Student’s t-test with Welch’s correction (S0 = 1, FDR < 5%), and
proteins with a significantly different expression level are shown in red on the plot. The point corresponding to
SLC4A2 is highlighted revealing preferential expression in neutrophils. All 30 candidate genes identified in
Figure 8 were analyzed through this comparative approach to examine preferential protein levels in neutrophils
above monocytes. (b) Isolated neutrophil lysates were analyzed by Western blotting under reducing and non-
reducing conditions using anti-SLC4A2 #2 antibody. In both lanes, two bands corresponding to glycosylated (~80
kDa) and nascent, non-glycosylated SLC44A2 are detected. (c) Healthy volunteers were genotyped to identify
individuals homozygous for the protective rs2288904-A/A SNP in SLC44A2. Representative chromatograms for
individuals with rs2288904-G/G, rs2288904-G/A, rs2288904-A/A genotypes are shown.
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Figure 8. SLC44A2 binds activated aIIbb3. (a) Graphical representation of relative neutrophil binding after 15 min
of leukocyte perfusion at 50 s 1 to activated aIIbb3 captured and activated by LIBS2/anti-b3 activating antibody in
the presence and absence of increasing concentrations of anti-SLC44A2#1 or #2 antibodies. Data plotted are
mean ± SD. Data were analyzed using One-Way ANOVA with multiple comparisons. (b) Representative
micrographs of neutrophils bound to activated aIIbb3 i) in the absence of antibody, ii) in the presence of control
IgG and iii) in the presence of anti-SLC44A2#1. (c) Graphical representation of the number of HEK293T cells
transfected with either SLC44A2-tGFP or SLC44A2(R154Q)-tGFP (shown in red) expression vectors binding to
activated aIIbb3 (captured and activated by LIBS2/anti-b3 activating antibody) after 10 min flow at 25 s
 1.
Experiments were performed in the presence and absence of either GR144053 or anti-SLC44A2#1 antibody. Data
presented are the mean number of bound cells per field of view. Data were analyzed using one-way ANOVA with
multiple comparisons. Inset shows a western blot of untransfected HEK293T cells, or HEK293T cells transfected
with either SLC44A2-tGFP or SLC44A2(R154Q)-tGFP and detected using an anti-tGFP mAb. Only tGFP (26 kDa)
Figure 8 continued on next page
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Figure 8 continued
fused to SLC44A2 (70 kDa) was detected in transfected cells; tGFP was uniformly associated with SLC44A2 and the
SLC44A2(R154Q) variant (d) Graphical representation of the number of HEK293T cells transfected with either
SLC44A2-tGFP or SLC44A2(R154Q)-tGFP (shown in red) expression vectors interacting with VWF-‘primed’
platelets. Plasma-free blood was first perfused at 1000 s 1 for 3.5 mins to capture and ‘prime’ the platelets, and
transfected HEK293T cells were subsequently perfused at 25 s 1 for 10 min, in the presence and absence of
GR144053 or anti-SLC44A2#1 antibody. HEK293T cells transfected with SLC44A2-tGFP or isolated neutrophils were
also perfused over VWF in the absence of platelets, for 30 mins at 25 s 1 or 50 s 1 respectively. Data presented
are the mean number of bound cells per field of view. Data were analyzed using one-way ANOVA with multiple
comparisons. (e) Representative micrographs of HEK293T cells transfected with i) SLC44A2-tGFP in the absence of
antibody, ii) SLC44A2-tGFP in the presence of anti-SLC44A2#1 antibody and iii) SLC44A2(R154Q)-tGFP bound to
activated VWF-‘primed’ platelets. (f) Graphical representation of the number of neutrophils rolling per minute on
VWF-‘primed’ platelets. PFB from individuals homozygous for the R154-encoding allele of SLC44A2(R154/R154) or
the Q154-encoding allele of SLC44A2(Q154/Q154) (shown in red), or heterozygotes SLC44A2(R154/Q154) (shown
in green) were perfused over ‘primed’ platelets for 10 min at 50 s 1 (see Video 7). Experiments were performed in
the presence and absence of anti-SLC44A2#1 or anti-SLC44A2#2 antibodies. Data plotted are mean ± SD. Data
were analyzed using one-way ANOVA with multiple comparisons.
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Figure 9. Analysis of platelet binding to FL-VWF under low/disturbed flow and subsequent leukocyte binding. (a) Schematic representation of blood
flow through bifurcated channels. Blood is drawn through inlets #1, #2 and #3, and out through outlet #4. For much of the channels, the flow is linear,
with particular exception to the bifurcation site on the right where disturbed flow exists due to convergence of flows. (b) Channels were coated with FL-
VWF and whole blood labeled with DiOC6 was perfused through channels as in a), and as denoted by arrows, at an exit shear rate of 50 s 1. At this low
shear rate, platelets can bind to the channel surface to which leukocytes (larger cells also stained in green) also bind. Although this is evident in the
linear part of the channel (inset), at the site of most turbulent flow increased platelet and leukocyte binding was observed. (c) As in b) except GR144053
was added to block aIIbb3. Blocking aIIbb3 inhibited the majority of leukocyte binding to platelets (the majority of those observed are in transit).
However, in the absence of leukocyte binding the binding of platelets to the VWF surface under low flow can be more clearly observed in both the
linear and turbulent flow areas.
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Figure 10. Model of platelet priming, neutrophil binding and NETosis. (1) Under normal conditions, VWF circulates in plasma in a globular
conformation that does not interact with platelets. Resting platelets present GPIba on their surface - in complex with GPIbb, GPIX and GPV - and also
aIIbb3 in its inactive conformation. (2) When VWF is attached to a cell surface (e.g. activated endothelial cell/Kuppfer cell or to a bacterial cell) or to an
exposed collagen surface under flow, VWF unravels to expose its A1 domain enabling capture of platelets via GPIba. (3) Binding of platelets to VWF
under flow induces mechano-unfolding of the juxtamembrane stalk of GPIba leading to intraplatelet signaling, release of intraplatelet Ca2+ stores and
activation of integrin aIIbb3.(4) Neutrophils can bind to activated aIIbb3 under flow via SLC44A2. (5) Shear forces on the neutrophil induce
mechanosensitive signaling into the neutrophil causing intracellular Ca2+ release and NADPH oxidase-dependent NETosis.
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